Apr 12 |
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
|
Apr 10 |
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
|
Apr 10 |
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
|
Apr 10 |
Amylyx down 6% despite encouraging phase 2 data on rare disorder drug
|
Apr 10 |
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
|
Apr 8 |
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
|
Apr 7 |
Wall Street Breakfast: The Week Ahead
|
Apr 6 |
Analysts Just Slashed Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) EPS Numbers
|
Apr 4 |
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
|
Apr 4 |
ALS drug will be pulled from US market after study showed patients didn't benefit
|